Avaleht › Ülekaalulisus › Nevada › Las Vegas
Ülekaalulisus kliinilised uuringud linnas Las Vegas, NV
23 uuringut haiguse Ülekaalulisus jaoks otsivad osalejaid linnas Las Vegas ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
VärbamineFaas 2
- Vector Clinical Trials /ID# 282265, Las Vegas
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
VärbamineFaas 3
- Palm Research Center Inc., Las Vegas
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
VärbamineFaas 3
- M3 Wake Research - Las Vegas Cimarron, Las Vegas
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
VärbamineFaas 3
- Research Site, Las Vegas
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
VärbamineFaas 3
- Palm Research Center Tenaya, Las Vegas
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
VärbamineFaas 3
- Excel Clinical Research, Las Vegas
- Vector Clinical Trials, Las Vegas
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
VärbamineFaas 3
- AMR Clinical, Las Vegas
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
VärbamineFaas 2
- Las Vegas Medical Research, Las Vegas
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
VärbamineFaas 3
- AURORA-1 Clinical Site, Las Vegas
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
VärbamineFaas 3
- AURORA-2 Clinical Site, Las Vegas
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
VärbamineFaas 3Terved vabatahtlikud oodatud
- ACCOMPLISH-2 Research Site, Las Vegas
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
VärbamineFaas 3
- Jubilee Clinical Research, Inc., Las Vegas
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
VärbamineFaas 2
- Las Vegas Medical Research, Las Vegas
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
VärbamineFaas 2
- Vector Clinical Trials, Las Vegas
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
VärbamineFaas 3
- Kailera Clinical Site, Las Vegas
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
VärbamineFaas 3
- Palm Research Center Inc, Las Vegas
- Vector Clinical Trials, Las Vegas
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
VärbamineFaas 3
- Kailera Clinical Site, Las Vegas
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
VärbamineFaas 3
- Palm Research Center Inc, Las Vegas
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
VärbamineFaas 3
- Excel Clinical Research, Las Vegas
Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.
VärbamineTerved vabatahtlikud oodatud
- University of Nevada, Las Vegas, Las Vegas
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
VärbamineFaas 3
- Research Site, Las Vegas
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
VärbamineFaas 3
- ACCOMPLISH-1 Research Site, Las Vegas
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
VärbamineFaas 1
- Corxel Investigational site, Las Vegas
Ülekaalulisus uuringud teistes linnades
- San Antonio, TX34 uuringut
- Houston, TX33 uuringut
- Chicago, IL28 uuringut
- Orlando, FL27 uuringut
- Miami, FL23 uuringut
- Atlanta, GA20 uuringut
- Dallas, TX20 uuringut
- New York City, NY19 uuringut
- Jacksonville, FL19 uuringut
- Washington, DC19 uuringut
- Austin, TX18 uuringut
- Baltimore, MD17 uuringut
Muud uuringud linnas Las Vegas
- Rasvumine27 uuringut
- 2. tüüpi diabeet18 uuringut
- Mitteväikerakuline kopsuvähk13 uuringut
- Suur depressiivne häire13 uuringut
- Rinnavähk10 uuringut
- Alzheimeri tõbi8 uuringut
- Eesnäärmevähk8 uuringut
- Äge müeloidne leukeemia8 uuringut
- Vähk (kõik liigid)8 uuringut
- Steatoosne maksahaigus7 uuringut
- Endomeetriumivähk7 uuringut
- Depressioon7 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.